Literature DB >> 12826966

Desflurane and sevoflurane attenuate oxygen and glucose deprivation-induced neuronal cell death.

L Wise-Faberowski1, M K Raizada, C Sumners.   

Abstract

Neuronal cell death may occur via two pathways: those causing necrosis or those causing apoptosis. Apoptosis can be activated during periods of stress such as oxygen and glucose deprivation. Anesthetic agents such as desflurane or sevoflurane can attenuate early neuronal necrotic death, but their effect on oxygen and glucose deprivation-induced apoptosis has not been investigated. Neuronal cell cultures were prepared from neonatal rat cortex and were used between 10 and 14 days in vitro. The neuronal cell cultures were pretreated 30 minutes prior to oxygen and glucose deprivation with either desflurane or sevoflurane (N = 18). Three concentrations of each anesthetic were evaluated. The cultures were then deprived of oxygen and glucose for 30, 60, or 90 minutes. Treatment with desflurane or sevoflurane was continued during the period of oxygen and glucose deprivation. Forty-eight hours after exposure, the cells were examined for apoptosis using TUNEL and DNA gel electrophoresis. Comparisons were made to neuronal cortical cell cultures exposed to oxygen and glucose deprivation alone (N = 9). This in vitro model of oxygen and glucose deprivation was successful in producing neuronal cell death during the exposure times examined. During 30-, 60-, and 90-minute periods of oxygen and glucose deprivation, both desflurane and sevoflurane significantly ( approximately 98%) attenuated neuronal cell death regardless of concentration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12826966     DOI: 10.1097/00008506-200307000-00006

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  6 in total

Review 1.  Anaesthetic-related neuroprotection: intravenous or inhalational agents?

Authors:  Daniela Schifilliti; Giovanni Grasso; Alfredo Conti; Vincenzo Fodale
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

2.  The changes of technetium-99m-labeled annexin-V in delayed anesthetic preconditioning during myocardial ischemia/reperfusion.

Authors:  Hong Xie; Xia Liu; Chen Wang; Jiang Zhu; Chen Yang; Chunfeng Liu; Hong Liu; Xuemei Wu
Journal:  Mol Biol Rep       Date:  2013-11-06       Impact factor: 2.316

3.  The anesthetic agent sevoflurane attenuates pulmonary acute lung injury by modulating apoptotic pathways.

Authors:  L Wang; Y Ye; H B Su; J P Yang
Journal:  Braz J Med Biol Res       Date:  2017-02-20       Impact factor: 2.590

4.  Argon attenuates the emergence of secondary injury after traumatic brain injury within a 2-hour incubation period compared to desflurane: an in vitro study.

Authors:  Linda Grüßer; Rosmarie Blaumeiser-Debarry; Matthias Krings; Benedikt Kremer; Anke Höllig; Rolf Rossaint; Mark Coburn
Journal:  Med Gas Res       Date:  2017-06-30

5.  Sevoflurane alleviates oxygen-glucose deprivation/reoxygenation-induced injury in HT22 cells through regulation of the PI3K/AKT/GSK3β signaling pathway.

Authors:  Qiong Yu; Haofei Dai; Yinan Jiang; Yifeng Zha; Jie Zhang
Journal:  Exp Ther Med       Date:  2021-02-19       Impact factor: 2.447

6.  Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury.

Authors:  Philip D Loetscher; Jan Rossaint; Rolf Rossaint; Joachim Weis; Michael Fries; Astrid Fahlenkamp; Yu-Mi Ryang; Oliver Grottke; Mark Coburn
Journal:  Crit Care       Date:  2009-12-17       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.